Protein Engineering Market
Protein Engineering Market Size, Share & Trends Analysis by Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Colony Stimulating Factor, Coagulation Factor, Vaccines, and Others), By Product (Instruments, Services and Software, and Reagents), and by End-User (Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Contract Research Organizations), Forecast Period (2026-2035)
Industry Overview
Protein engineering market was valued at $3.5 billion in 2025 and is projected to reach $15.8 billion by 2035, growing at a CAGR of 16.4% during the forecast period (2026-2035). The market is driven by the increasing demand for personalized medicine, biopharmaceuticals, and advanced therapies for conditions like cancer and autoimmune diseases. Factors such as rising investments in synthetic biology, technological advancements (including AI/ML in protein design), and the growing need for novel enzymes in the agrochemical and biofuel industries are also fueling growth. Restraining factors include the high cost of equipment and development, though this is being mitigated by AI and automation.
Market Dynamics
Rising Demand for Biologics and Precision Therapeutics
One of the strongest drivers for the global protein engineering market is the rapid expansion of biologics, including monoclonal antibodies, engineered enzymes, therapeutic proteins, and next-generation modalities such as bispecific antibodies and antibody–drug conjugates. Pharmaceutical and biotechnology companies increasingly rely on engineered proteins to enhance drug specificity, reduce toxicity, and improve delivery efficiency. As biologics gain a larger share of the global pharmaceutical pipeline, demand for protein engineering tools, computational platforms, and screening technologies continues to rise. This trend is also strengthened by increasing approvals of protein-based therapeutics, greater investment in targeted therapies, and the growing emphasis on personalised medicine.
Technological Advancements in AI, Computational Design, and Directed Evolution
Technological innovation remains a core driver, particularly the integration of artificial intelligence (AI), machine learning, and advanced computational tools for protein modelling and design. AI-driven platforms significantly improve the accuracy of protein structure prediction, enabling faster design cycles and reducing the cost of experimental work. At the same time, directed evolution techniques, high-throughput screening, CRISPR-based engineering, and automation systems are enhancing efficiency, scalability, and reproducibility across research and development workflows. These advancements collectively increase success rates in protein optimisation and expand the range of commercially viable engineered proteins across therapeutic, industrial, and diagnostic applications.
Growing R&D Spending and Outsourcing Across Biopharma and Industrial Sectors
Rising global expenditure on biotechnology and life-science research is another key factor accelerating market growth. Pharmaceutical companies, academic institutions, and CROs/CMOs are investing heavily in protein characterisation, structural biology, enzyme engineering, and synthetic biology. As protein design becomes more complex, many organisations increasingly outsource engineering activities to specialised service providers, boosting demand for contract research, computational design services, and custom protein production. Additionally, the expanding adoption of engineered proteins in non-pharma industries such as food processing, biofuels, agriculture, and environmental biotechnology further broadens market penetration and creates multiple revenue streams that support long-term market expansion.
Market Segmentation
- Based on the protein type, the market is segmented into monoclonal antibodies, insulin, erythropoietin, interferon, colony-stimulating factor, coagulation factor, vaccines, and others.
- Based on product, the market is segmented into instruments, service and, software, and reagents.
- Based on the end user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, and contract research organizations.
Pharmaceutical and Biotechnology Companies Segment to Grow at a Considerable Market Share
The Pharmaceutical and Biotechnology Companies segment stands out as the largest and leading segment. This dominance is driven by the heavy concentration of R&D investments, extensive biologics pipelines, and the continuous development of engineered therapeutic proteins such as monoclonal antibodies, insulin analogs, erythropoietin, interferons, and colony-stimulating factors. Pharma and biotech companies are the primary users of instruments, reagents, AI-driven protein design platforms, and advanced engineering services, as they rely on protein engineering to develop drugs with improved potency, stability, and manufacturability. Their high spending on preclinical and clinical research, rapid adoption of computational engineering tools, and growing use of contract research organizations further reinforce their leadership. As biologics continue to expand globally, becoming a cornerstone of modern therapeutics, pharmaceutical and biotechnology companies remain the central force driving revenue, innovation, and market growth across the entire protein engineering ecosystem.
Monoclonal Antibodies: A Key Segment in Market Growth
Among all protein types and product categories, monoclonal antibodies (mAbs) stand out as the key segment driving market growth, supported strongly by the rising global demand for targeted biologics, immunotherapies, and next-generation antibody formats. Monoclonal antibodies dominate due to their widespread use in oncology, autoimmune diseases, infectious diseases, and chronic inflammatory conditions, making them the highest-value class of engineered proteins. Their extensive clinical pipeline, high approval rates, and continuous innovation, such as bispecific mAbs, antibody–drug conjugates, Fc-engineered antibodies, and humanized variants, further strengthen their market contribution. At the product level, reagents represent a major revenue-generating segment because they are essential across all stages of protein engineering workflows, from cloning and mutagenesis to expression, purification, and assay development. Reagents show strong recurring demand and benefit from expanding R&D activities and high-throughput screening systems.
However, when considering both categories together, mAbs remain the single most influential driver of market expansion due to their clinical importance, broad therapeutic applications, and heavy investment by biopharmaceutical companies. Their dominance is reinforced by increasing outsourcing for antibody engineering services, rising adoption of AI-based antibody design, and the growing number of blockbuster antibody therapies fueling sustained, long-term growth.
Regional Outlook
The global protein engineering market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region to Hold a Substantial Growth Rate
In North America, the US dominates the global protein engineering market with a major share, driven by its strong biotechnology ecosystem, advanced research infrastructure, and substantial investments in biologics development and precision medicine. The country hosts the world’s largest concentration of pharmaceutical and biotech companies, academic research institutes, and contract research organizations (CROs) that actively integrate protein engineering into drug discovery, enzyme development, and therapeutic optimization. The US leads in adopting cutting-edge technologies such as AI-driven protein modelling, high-throughput screening, directed evolution platforms, and CRISPR-based engineering, which significantly accelerate innovation and commercialisation.
A high volume of ongoing clinical trials for monoclonal antibodies, therapeutic proteins, and next-generation biologics strengthens its position further, supported by strong regulatory frameworks and sustained government funding through agencies like the NIH and NSF. Moreover, major industry players - Thermo Fisher Scientific, Danaher, Merck KGaA’s MilliporeSigma (US operations), Agilent Technologies, and leading antibody engineering companies are headquartered or heavily active in the U.S., enabling rapid technology adoption and large-scale production capabilities. The presence of AI-biotech startups and partnerships between technology companies and biopharma enterprises further reinforces the country’s leadership, making the US the clear dominant force in the global protein engineering market.
Market Players Outlook
The major companies operating in the global protein engineering market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., GenScript Biotech Corp., Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisitions to expand their businesses and develop innovative products to maintain their market positioning.
Recent Development
- In July 2025, a new AI-informed method accelerates protein engineering by introducing AiCE (AI-informed Constraints for protein Engineering), which allows for rapid protein evolution through a generic inverse folding model. This approach overcomes traditional protein engineering challenges, offering improved cost-effectiveness, efficiency, and scalability compared to existing AI methods, which are often computationally intensive.
- In September 2024, AlphaProteo is an innovative AI system capable of designing novel proteins that bind to specific target molecules, thereby enhancing research in biology and health. These proteins play a crucial role in regulating various biological processes within the body. Although tools like AlphaFold have advanced our understanding of protein interactions, they do not create new proteins. The novel binders generated by AlphaProteo can facilitate drug development, disease diagnosis, and even enhance crop resistance, although current methods still require substantial experimental validation.
The Report Covers
- Market value data analysis for 2026 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global protein engineering market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Protein Engineering Market Sales Analysis – Protein Type | Product | End-User ($ Million)
- Protein Engineering Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Protein Engineering Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Global Protein Engineering Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Protein Engineering Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Protein Engineering Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Protein Engineering Market Revenue and Share by Manufacturers
- Protein Engineering Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Agilent Technologies Inc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Bio-Rad Laboratories Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Bruker Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- GenScript Biotech Corp.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Agilent Technologies Inc
- Key Company Analysis
- Global Protein Engineering Market Sales Analysis by Protein Type ($ Million)
- Monoclonal Antibodies
- Insulin
- Erythropoietin
- Interferon
- Colony Stimulating Factor
- Coagulation Factor
- Vaccines
- Others (Growth Hormones)
- Global Protein Engineering Market Sales Analysis by Product ($ Million)
- Instruments
- Service and Software
- Reagents
- Global Protein Engineering Market Sales Analysis by End-Users ($ Million)
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Regional Analysis
- North American Protein Engineering Market Sales Analysis – Protein Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Protein Engineering Market Sales Analysis – Protein Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Protein Engineering Market Sales Analysis – Protein Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Protein Engineering Market Sales Analysis – Protein Type | Product | End-User | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abcam plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Agilent Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Amgen, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bruker Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Codexis, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Co.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GE Healthcare
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genentech, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Genscript Biotech Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lonza Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PerkinElmer, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Promega Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sigma-Aldrich Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Twist Bioscience Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Waters Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abcam plc
1. Global Protein Engineering Market Research and Analysis by Protein Type, 2025–2035 ($ Million)
2. Global Monoclonal Antibodies Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Insulin Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Erythropoietin Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Interferon Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Colony Stimulating Factor Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Coagulation Factor Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Vaccines Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Other Type Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Protein Engineering Market Research and Analysis by Product, 2025–2035 ($ Million)
11. Global Protein Engineering Instruments Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Protein Engineering Service and Software Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Protein Engineering Reagents Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Protein Engineering Market Research and Analysis by End-Users, 2025–2035 ($ Million)
15. Global Protein Engineering For Academic Research Institutes Market Research and Analysis by Region, 2025–2035 ($ Million)
16. Global Protein Engineering For Pharmaceutical and Biotechnology Companies Market Research and Analysis by Region, 2025–2035 ($ Million)
17. Global Protein Engineering For Contract Research Organizations (CROs) Market Research and Analysis by Region, 2025–2035 ($ Million)
18. Global Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
19. North American Protein Engineering Market Research and Analysis by Country, 2025–2035 ($ Million)
20. North American Protein Engineering Market Research and Analysis by Protein Type, 2025–2035 ($ Million)
21. North American Protein Engineering Market Research and Analysis by Product, 2025–2035 ($ Million)
22. North American Protein Engineering Market Research and Analysis by End-Users, 2025–2035 ($ Million)
23. European Protein Engineering Market Research and Analysis by Country, 2025–2035 ($ Million)
24. European Protein Engineering Market Research and Analysis by Protein Type, 2025–2035 ($ Million)
25. European Protein Engineering Market Research and Analysis by Product, 2025–2035 ($ Million)
26. European Protein Engineering Market Research and Analysis by End-Users, 2025–2035 ($ Million)
27. Asia-Pacific Protein Engineering Market Research and Analysis by Country, 2025–2035 ($ Million)
28. Asia-Pacific Protein Engineering Market Research and Analysis by Protein Type, 2025–2035 ($ Million)
29. Asia-Pacific Protein Engineering Market Research and Analysis by Product, 2025–2035 ($ Million)
30. Asia-Pacific Protein Engineering Market Research and Analysis by End User, 2025–2035 ($ Million)
31. Rest of the World Protein Engineering Market Research and Analysis by Region, 2025–2035 ($ Million)
32. Rest of the World Protein Engineering Market Research and Analysis by Protein Type, 2025–2035 ($ Million)
33. Rest of the World Protein Engineering Market Research and Analysis by Product, 2025–2035 ($ Million)
34. Rest of the World Protein Engineering Market Research and Analysis by End User, 2025–2035 ($ Million)
1. Global Protein Engineering Market Share by Protein Type, 2025 vs 2035 (%)
2. Global Monoclonal Antibodies Protein Engineering Market Share by Region, 2025 vs 2035 (%)
3. Global Insulin Protein Engineering Market Share by Region, 2025 vs 2035 (%)
4. Global Erythropoietin Protein Engineering Market Share by Region, 2025 vs 2035 (%)
5. Global Interferon Protein Engineering Market Share by Region, 2025 vs 2035 (%)
6. Global Colony Stimulating Factor Protein Engineering Market Share by Region, 2025 vs 2035 (%)
7. Global Coagulation Factor Protein Engineering Market Share by Region, 2025 vs 2035 (%)
8. Global Vaccines Protein Engineering Market Share by Region, 2025 vs 2035 (%)
9. Global Other Type Protein Engineering Market Share by Region, 2025 vs 2035 (%)
10. Global Protein Engineering Market Share by Product, 2025 vs 2035 (%)
11. Global Protein Engineering Instruments Market Share by Region, 2025 vs 2035 (%)
12. Global Protein Engineering Service and Software Market Share by Region, 2025 vs 2035 (%)
13. Global Protein Engineering Reagents Market Share by Region, 2025 vs 2035 (%)
14. Global Protein Engineering Market Share by End-Users, 2025 vs 2035 (%)
15. Global Protein Engineering for Academic Research Institutes Market Share by Region, 2025 vs 2035 (%)
16. Global Protein Engineering for Pharmaceutical and Biotechnology Companies Market Share by Region, 2025 vs 2035 (%)
17. Global Protein Engineering for Contract Research Organizations (CROs) Market Share by Region, 2025 vs 2035 (%)
18. Global Protein Engineering Market Share by Region, 2025 Vs 2035 (%)
19. US Protein Engineering Market Size, 2025–2035 ($ Million)
20. Canada Protein Engineering Market Size, 2025–2035 ($ Million)
21. UK Protein Engineering Market Size, 2025–2035 ($ Million)
22. France Protein Engineering Market Size, 2025–2035 ($ Million)
23. Germany Protein Engineering Market Size, 2025–2035 ($ Million)
24. Italy Protein Engineering Market Size, 2025–2035 ($ Million)
25. Spain Protein Engineering Market Size, 2025–2035 ($ Million)
26. Russia Protein Engineering Market Size, 2025–2035 ($ Million)
27. Rest of Europe Protein Engineering Market Size, 2025–2035 ($ Million)
28. India Protein Engineering Market Size, 2025–2035 ($ Million)
29. China Protein Engineering Market Size, 2025–2035 ($ Million)
30. Japan Protein Engineering Market Size, 2025–2035 ($ Million)
31. South Korea Protein Engineering Market Size, 2025–2035 ($ Million)
32. Australia and New Zealand Protein Engineering Market Size, 2025–2035 ($ Million)
33. ASEAN Economies Protein Engineering Market Size, 2025–2035 ($ Million)
34. Rest of Asia-Pacific Protein Engineering Market Size, 2025–2035 ($ Million)
35. Latin America Protein Engineering Market Size, 2025–2035 ($ Million)
36. Middle East and Africa Protein Engineering Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Protein Engineering Market in 2025 is estimated to be around $3.5 billion.
North America holds the largest share in the Protein Engineering Market.
Leading players in the Protein Engineering Market include Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corp., GenScript Biotech Corp., Thermo Fisher Scientific Inc., among others.
Protein Engineering Market is expected to grow at a CAGR of 16.4% from 2026 to 2035.
Growing demand for biologics, advances in protein design technologies, expanding applications in drug discovery and industrial biotechnology, and increased R&D investment are driving the protein engineering market growth.
